Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
Background: COPD affects millions of people worldwide. Poor treatment adherence contributes to increased symptom severity, morbidity and mortality. This study was designed to investigate adherence to COPD treatment in Turkey and Saudi Arabia. Methods: An observational, cross-sectional study in adult COPD patients in Turkey and Saudi Arabia. Through physician-led interviews, data were collected on sociodemographics and disease history, including the impact of COPD on health status using the COPD Assessment Test (CAT); quality of life, using the EuroQol Five-Dimension questionnaire (EQ-5D); and anxiety and depression using the Hospital Anxiety and Depression Scale (HADS). Treatment adherence was measured using the 8-item Morisky Medication Adherence Scale (MMAS-8). Multivariate logistic regression analysis examined the predictors of non-adherence and the impact of adherence on symptom severity. Results: Four hundred and five COPD patients participated: 199 in Turkey and 206 in Saudi Arabia. Overall, 49.2% reported low adherence (MMAS-8 <6). Of those, 74.7% reported high disease impact (CAT >15) compared to 58.4% reporting medium/high adherence ( p =0.0008). Patients with low adherence reported a lower mean 3-level EQ-5D utility value (0.54±0.35) compared to those with medium/high adherence (0.64±0.30; p <0.0001). Depression with HADS score 8–10 or >10 was associated with lower adherence (OR 2.50 [95% CI: 1.43–4.39] and 2.43 [95% CI: 1.39–4.25], respectively; p =0.0008). Being a high school/college graduate was associated with better adherence compared with no high school (OR 0.57 [95% CI: 0.33–0.98] and 0.38 [95% CI: 0.15–1.00], respectively; p =0.0310). After adjusting for age, gender, and country, a significant association between treatment adherence (MMAS-8 score ≥6) and lower disease impact (CAT ≤15) was observed (OR 0.56 [95% CI: 0.33–0.95]; p =0.0314). Conclusion: Adherence to COPD treatment is poor in Turkey and Saudi Arabia. Non-adherence to treatment is associated with higher disease impact and reduced quality of life. Depression, age, and level of education were independent determinants of adherence. Keywords: COPD, non-adherence, 8-item Morisky Medication Adherence Scale, MMAS-8, EuroQol Five-Dimension questionnaire, EQ-5D, COPD Assessment Test, CAT, Turkey, Saudi Arabia
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it was demonstrated that the prevalence of low medication adherence was 64.2% among COPD patients in Saudi Arabia and neighboring regions”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“and a significant predictor of low adherence included living in Saudi Arabia rather than Turkey (OR = 3.20).”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [9]
The cited source says what the claim attributes to it.
In the citing paper
“Previous regional studies, including the ADCARE study, demonstrated suboptimal adherence to COPD treatments among patients in Saudi Arabia and neighboring countries and suggested associations between lower adherence and poorer clinical outcomes [9].”
From Chronic Obstructive Pulmonary Disease in the Gulf Cooperation Council: Acute-Care Utilization and Medication Adherence: A PRISMA-ScR Scoping Review (2026) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Retracted: Predictive Validity of a Medication Adherence Measure in an Outpatient Setting
Morisky, D. E., Ang, A., Krousel‐Wood, M., & Ward, H. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07572.x · Cited by 2,877 · cited 1×
“0 were categorized as medium and high adherence, respectively.(17) Written permission was obtained from the copyright owners of the MMAS-8 questionnaire for any excerpts from copyrighted works that are included and the sources have been credited in the article.”
MethodRetractedThe Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Depression and quality of life in older persons: A review
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000437299 · Cited by 14,152
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177 · cited 1×
“49 An association between depression and poor treatment adherence in chronic disease, 50 and specifically in respiratory diseases such as asthma 51 and COPD, 52 has been reported in the literature.”
Development and first validation of the COPD Assessment Test
Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W.-H., & Kline Leidy, N. (2009) · European Respiratory Journal · doi:10.1183/09031936.00102509 · Cited by 3,198 · cited 1×
“PrOs The impact of COPD on health status was assessed using the 8-item COPD Assessment Test (CAT).(11) In this study, a CAT score of ,10 equates to low impact, 10–15 signifies medium impact, and .”
MethodBestall, J. C., Paul, E. A., Garrod, R., Garnham, R., Jones, P. W., & Wedzicha, J. A. (1999) · Thorax · doi:10.1136/thx.54.7.581 · Cited by 2,927
Kassebaum, N. J., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, J., Carter, A., Casey, D. C., Charlson, F. J., Coates, M. M., Coggeshall, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31460-x · Cited by 2,163
Eisner, M. D., Anthonisen, N., Coultas, D., Kuenzli, N., Perez-Padilla, R., Postma, D., Romieu, I., Silverman, E. K., & Balmes, J. R. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200811-1757st · Cited by 978 · cited 1×
“Smoking is considered to be a major risk factor for COPD 19 and smoking rates in the Middle East and North Africa (MENA) are known to be high.”
Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (2013) · PsycTESTS Dataset · doi:10.1037/t03589-000 · Cited by 946
New medication adherence scale versus pharmacy fill rates in seniors with hypertension.
Krousel-Wood, M. A., Islam, T., Webber, L. S., Ré, R. N., Morisky, D. E., & Muntner, P. (2009) · PubMed · Cited by 683
Surprisingly High Prevalence of Anxiety and Depression in Chronic Breathing Disorders
Kunik, M. E., Roundy, K., Veazey, C., Souchek, J., Richardson, P., Wray, N. P., & Stanley, M. A. (2005) · Chest · doi:10.1016/s0012-3692(15)34468-8 · Cited by 650
Ng, T.-P. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.1.60 · Cited by 624 · cited 1×
“Depression is known to be an important comorbidity of COPD,(48) which is often untreated and is associated with poorer health outcomes.(49) An association between depression and poor treatment adherence in chronic disease,(50) and specifically in respiratory diseases such as asthma(51) and COPD,(52) has been reported…”
BackgroundChronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Sin, D. D., & Man, S. F. P. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200404-032ms · Cited by 572 · cited 1×
“23 COPD has also been independently associated with multiple conditions such as coronary heart disease 24 and lung cancer.”
Health status measurement in chronic obstructive pulmonary disease
Jones, P. W. (2001) · Thorax · doi:10.1136/thorax.56.11.880 · Cited by 557 · cited 1×
“This is not an unusual finding, lower FEV 1 has been shown to be associated with worse health, but the correlation is low, implying that some patients may have very poor health despite mild impairment in lung function.(44) CAT scores can show significant impairment in health status across all COPD severities, even in…”
Adherence to inhaled therapy, mortality and hospital admission in COPD
Vestbo, J., Anderson, J. A., Calverley, P. M. A., Celli, B., Ferguson, G. T., Jenkins, C., Knobil, K., Willits, L. R., Yates, J. C., & Jones, P. W. (2009) · Thorax · doi:10.1136/thx.2009.113662 · Cited by 516 · cited 1×
“Data from the TORCH study reports no association between adherence to treatment and symptom severity as defined by Global Initiative for Obstructive Lung Disease (GOLD) stage, although patients with poor adherence did have lower baseline FEV 1 and increased dyspnea.(42) Similar findings were reported by another study…”
ResultKurmi, O. P., Semple, S., Simkhada, P., Smith, W. C. S., & Ayres, J. G. (2010) · Thorax · doi:10.1136/thx.2009.124644 · Cited by 439 · cited 6×
“49 An association between depression and poor treatment adherence in chronic disease, 50 and specifically in respiratory diseases such as asthma 51 and COPD, 52 has been reported in the literature.”
InfluentialImproving the measurement of self-reported medication nonadherence: Response to Authors
Morisky, D. E., & DiMatteo, M. R. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.002 · Cited by 374
Properties of the COPD assessment test in a cross-sectional European study
Jones, P. W., Brusselle, G., Dal Negro, R. W., Ferrer, M., Kardos, P., Levy, M. L., Perez, T., Soler Cataluña, J. J., van der Molen, T., Adamek, L., et al. (2011) · European Respiratory Journal · doi:10.1183/09031936.00177210 · Cited by 341 · cited 1×
“CAT scores can show significant impairment in health status across all COPD severities, even in patients with mild disease, regardless of whether severity was assessed by a physician or classified by GOLD stage.(45) Adherence to treatment for chronic diseases is a complex area.”
BackgroundHealth-related quality of life is related to COPD disease severity
Ståhl, E., Lindberg, A., Jansson, S.-A., Rönmark, E., Svensson, K., Andersson, F., Löfdahl, C.-G., & Lundbäck, B. (2005) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-3-56 · Cited by 340
Factors Associated With Medication Nonadherence in Patients With COPD
George, J., Kong, D. C. M., Thoman, R., & Stewart, K. (2005) · Chest · doi:10.1378/chest.128.5.3198 · Cited by 321 · cited 1×
“5 It has also been reported that patients with poor adherence often have insufficient understanding of their disease and its management options, and tend to rely more on natural remedies, 55 which could be linked to patient education.”
Risk Taking, Depression, Adherence, and Symptom Control in Adolescents and Young Adults with Asthma
Bender, B. G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200511-1706pp · Cited by 186 · cited 1×
“49 An association between depression and poor treatment adherence in chronic disease, 50 and specifically in respiratory diseases such as asthma 51 and COPD, 52 has been reported in the literature.”
Long-term metered-dose inhaler adherence in a clinical trial. The Lung Health Study Research Group.
Rand, C. S., Nides, M., Cowles, M. K., Wise, R. A., & Connett, J. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.2.7633711 · Cited by 182 · cited 1×
“Some studies have found that subjects who are older and better educated are more likely to be adherent to treatment.(43,53) Other studies have shown no significant association.”
BackgroundSmoking habits in the Middle East and North Africa: Results of the BREATHE study
Khattab, A., Javaid, A., Iraqi, G., Alzaabi, A., Ben Kheder, A., Koniski, M.-L., Shahrour, N., Taright, S., Idrees, M., Polatli, M., et al. (2012) · Respiratory Medicine · doi:10.1016/s0954-6111(12)70011-2 · Cited by 182 · cited 2×
“5% of women.(20) Interestingly in this study, ~30% of patients in Saudi Arabia stated they were non-smokers.”
BackgroundFactors Associated with Medication Adherence in Patients with Chronic Obstructive Pulmonary Disease
Agh, T., Inotai, A., & Meszaros, A. (2011) · Respiration · doi:10.1159/000324453 · Cited by 157 · cited 2×
“Some studies suggest that better quality of life leads to low adherence to treatment, as a result of the patient’s perception of the benefits versus risk of taking their medication.(40) Other studies suggest that, in line with the findings presented here, non-adherence to the prescribed treatment regimen is correlated…”
BackgroundResultKhdour, M. R., Hawwa, A. F., Kidney, J. C., Smyth, B. M., & McElnay, J. C. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1279-5 · Cited by 146 · cited 1×
“Other studies have shown no significant association.(46) Some studies suggest that older age is a risk factor for non-adherence due to factors such as cognitive impairment, particularly forgetfulness and polypharmacy.”
BackgroundClinical pharmacy‐led disease and medicine management programme for patients with COPD
Khdour, M. R., Kidney, J. C., Smyth, B. M., & McElnay, J. C. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03493.x · Cited by 145
Predictors of Patient Adherence to Long-term Home Nebulizer Therapy for COPD
Turner, J. G., Wright, E. C., Mendella, L., & Anthonisen, N. R. (1995) · CHEST Journal · doi:10.1378/chest.108.2.394 · Cited by 112 · cited 2×
“Similar findings were reported by another study investigating long-term adherence to home nebulizer use.(43) Other studies report no significant association between adherence and severity, measured by FEV 1 .”
Risk factors for chronic obstructive lung disease in Saudi Arabia
Døssing, M., Khan, J. H., & Alrabiah, F. A. (1994) · Respiratory Medicine · doi:10.1016/s0954-6111(05)80334-8 · Cited by 102 · cited 1×
“Indoor exposure to smoke from open wood fires or burning of biomass fuels has previously been found to be a risk factor for COPD among Saudi women.(23) COPD has also been independently associated with multiple conditions such as coronary heart disease(24) and lung cancer.”
BackgroundSelf-citationThe influence of COPD on health-related quality of life independent of the influence of comorbidity
VANMANEN, J., Bindels, P., Dekker, F. W., Bottema, B. J. A. M., van der Zee, J. S., IJzermans, C. J., & Schade, E. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00208-7 · Cited by 102
Kiri, V. A., Soriano, J. B., Visick, G., & Fabbri, L. M. (2009) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2009.00048 · Cited by 99 · cited 1×
“COPD has also been independently associated with multiple conditions such as coronary heart disease(24) and lung cancer.(25) Therefore, it is not surprising that given the age of the subjects and the high prevalence of smoking, which is itself known to be a risk factor for many of these diseases,(26) the majority of t…”
BackgroundKrauskopf, K., Federman, A. D., Kale, M. S., Sigel, K. M., Martynenko, M., O’Conor, R., Wolf, M. S., Leventhal, H., & Wisnivesky, J. P. (2015) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2014.922067 · Cited by 97
Improving the measurement of self-reported medication nonadherence: Response to Authors
Voils, C. I., Hoyle, R. H., Thorpe, C. T., Maciejewski, M. L., & Yancy, W. S. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.02.023 · Cited by 89
Assessment of the factors affecting the failure to use inhaler devices before and after training
Aydemir, Y. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.02.011 · Cited by 83 · cited 1×
“In Turkey, there are very few studies investigating COPD treatment adherence, and most of those that have been published are single-center studies and focus on parameters such as inhaler technique.(33) One Turkish study carried out in a single center, with a sample size of 59 patients, was designed principally to vali…”
BackgroundIngebrigtsen, T. S., Marott, J. L., Nordestgaard, B. G., Lange, P., Hallas, J., Dahl, M., & Vestbo, J. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-3029-0 · Cited by 71
Home Nebulized Therapy for Patients with COPD
Corden, Z. M., Bosley, C., Rees, P. J., & Cochrane, G. M. (1997) · CHEST Journal · doi:10.1378/chest.112.5.1278 · Cited by 69 · cited 1×
“41 Further research is needed to understand this complex relationship.”
Albrecht, J. S., Park, Y., Hur, P., Huang, T.-Y., Harris, I., Netzer, G., Lehmann, S. W., LANGENBERG, P. W., Khokhar, B., Wei, Y. J., et al. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201602-136oc · Cited by 65 · cited 6×
“49 An association between depression and poor treatment adherence in chronic disease, 50 and specifically in respiratory diseases such as asthma 51 and COPD, 52 has been reported in the literature.”
InfluentialDisease Burden of Mild Asthma: Findings from a Cross-Sectional Real-World Survey
Ding, B., & Small, M. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0520-0 · Cited by 61 · cited 1×
“Adherence was measured using the MMAS-8 – a scale that has been used widely to investigate adherence to medication in many disease areas including asthma 27–29 and COPD, 30–32 where it has been used to investigate adherence to inhaled medications.”
Solem, C. T., Sun, S. X., Sudharshan, L., Macahilig, C. P., Katyal, M., & Gao, X. (2013) · International Journal of COPD · doi:10.2147/copd.s51245 · Cited by 60 · cited 1×
“COPD is known to be a severely debilitating disease and has a substantially negative impact on the quality of life, 35 and the extent of this impact has been linked to the severity of the disease as measured by the number or severity of exacerbations, 36,37 and lung function, 38 and the CAT score.”
Llor, C., Molina, J., Naberán, K., Cots, J. M., Ros, F., Miravitlles, M., & the EVOCA study group (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01707.x · Cited by 58 · cited 1×
“COPD is known to be a severely debilitating disease and has a substantially negative impact on the quality of life, 35 and the extent of this impact has been linked to the severity of the disease as measured by the number or severity of exacerbations, 36,37 and lung function, 38 and the CAT score.”
Najjar, A., Amro, Y., Kitaneh, I., Abu-Sharar, S., Sawalha, M., Jamous, A., Qiq, M., Makharzeh, E., Laban, B. S., Amro, W., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129240 · Cited by 57 · cited 1×
“In line with this, a recent study carried out among Palestinian geriatrics living with chronic disease reported a correlation between a higher level of knowledge about the medication and improved adherence to the treatment.(56) ADCARE is one of the few studies addressing adherence to treatment in a real-life setting i…”
ResultMin, S. Y., Park, D., Yun, S., Kim, Y., Lee, J., Kang, S., Lee, S., Lee, C. W., Kim, J., Park, S., et al. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.890053 · Cited by 55
The effects of anxiety and depression symptoms on treatment adherence in COPD patients
Turan, O., Yemez, B., & İtil, O. (2013) · Primary Health Care Research & Development · doi:10.1017/s1463423613000169 · Cited by 55 · cited 1×
“One such study was carried out in 78 patients in Turkey and showed that the presence of depressive symptoms was associated with low adherence to treatment.(47) These findings are in line with the data presented here describing a significant correlation between depression and non-adherence to treatment.”
ResultMedication adherence among patients with chronic conditions in Italy
Napolitano, F., Napolitano, P., Angelillo, I. F., & Collaborative Working Group (2016) · The European Journal of Public Health · doi:10.1093/eurpub/ckv147 · Cited by 53 · cited 1×
“3% of outpatients with chronic conditions were adherent to their medication over the 4 weeks preceding their physician visit.(4) A separate study in Saudi Arabia investigating medication use for chronic conditions reported that only 32.”
BackgroundÖzyılmaz, E., Köktürk, N., Teksut, G., & Tatlicioğlu, T. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12150 · Cited by 48 · cited 1×
“In Turkey, there are very few studies investigating COPD treatment adherence, and most of those that have been published are single-center studies 8–10 and focus on parameters such as inhaler technique.”
Chiu, K.-C., Boonsawat, W., Cho, S., Cho, Y. J., Hsu, J., Liam, C. K., Muttalif, A. R., Nguyen, H., Nguyen, V. N., Wang, C., et al. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.898772 · Cited by 48 · cited 1×
“Adherence was measured using the MMAS-8 – a scale that has been used widely to investigate adherence to medication in many disease areas including asthma 27–29 and COPD, 30–32 where it has been used to investigate adherence to inhaled medications.”
Factors associated with medication nonadherence in patients with COPD
George, J., Kong, D. C. M., Thoman, R., & Stewart, K. (2006) · Respiratory Medicine COPD Update · doi:10.1016/j.rmedu.2006.03.034 · Cited by 47
Oğuzülgen, İ. K., Köktürk, N., & Işıkdoğan, Z. (2014) · Tuberkuloz ve Toraks · doi:10.5578/tt.7401 · Cited by 41 · cited 1×
“…with a sample size of 59 patients, was designed principally to validate the Turkish version of the MMAS-8 questionnaire and reported that 46.4% of COPD patients had low adherence to treatment, 9 which is comparable to the findings presented here, where 34.7% of COPD patients reported low adherence.”
InfluentialGuénette, L., Breton, M.-C., Grégoire, J., Jobin, M.-S., Bolduc, Y., Boulet, L., Dorval, E., & Moisan, J. (2014) · Journal of Asthma · doi:10.3109/02770903.2014.999084 · Cited by 32
The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey).
Yorgancıoğlu, A., Türktaş, H., Kalaycı, Ö., Yardım, N., Buzğan, T., Kocabaş, A., Karlıkaya, C., Yıldız, F., Ergün, P., Mungan, D., et al. (2009) · PubMed · Cited by 28
Shrestha, R., Pant, A., Shrestha, S., Shrestha, B., Gurung, R., & Karmacharya, B. (2015) · Kathmandu University Medical Journal · doi:10.3126/kumj.v13i1.13756 · Cited by 28 · cited 1×
“Some studies suggest that older age is a risk factor for non-adherence due to factors such as cognitive impairment, particularly forgetfulness and polypharmacy.(54) A recent study carried out in Saudi Arabia, based on the findings from a National household survey, reported that older age was associated with better tre…”
BackgroundHollingworth, K., Müllerová, H., Landis, S., Айсанов, З. Р., Davis, K. J., Ichinose, M., Mannino, D. M., Maskell, J., Menezes, A. M. B., van der Molen, T., et al. (2016) · International Journal of COPD · doi:10.2147/copd.s102280 · Cited by 28 · cited 1×
“based on the Continuing to Confront COPD International Patient Survey data reports an association between low medication adherence (measured using the MMAS-8) and increased symptom severity (measured by CAT).(30) This is in line with the ADCARE data, which demonstrates that, overall, there is a greater proportion of p…”
MethodMoradi‐Lakeh, M., Bcheraoui, C. E., Daoud, F., Tuffaha, M., Wilson, S., Saeedi, M. A., Basulaiman, M., Memish, Z. A., AlMazroa, M. A., Rabeeah, A. A. A., et al. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3904 · Cited by 25 · cited 2×
“7% of medications were used exactly as prescribed.(5) Reported adherence to COPD therapy specifically is poor.”
BackgroundKönigsdorfer, N., Jörres, R. A., Söhler, S., Welte, T., Behr, J., Ficker, J. H., Bals, R., Watz, H., Lutter, J. I., Lucke, T., et al. (2019) · Patient Preference and Adherence · doi:10.2147/ppa.s223438 · Cited by 13
Health Status of Patients with Chronic Obstructive Pulmonary Disease by Symptom Level
Marvel, J., Yu, T., Wood, R. P., Small, M., Higgins, V., & Make, B. J. (2016) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.3.3.2015.0177 · Cited by 12
Waist Circumference and Spirometric Measurements in Chronic Obstructive Pulmonary Disease
Foumani, A. A., Neyaragh, M. M., Ranjbar, Z. A., Leyli, E. K., Ildari, S., & Jafari, A. (2019) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2019.10.4.07 · Cited by 9
Patients adherence to treatment and knowledge about chronic obstructive pulmonary disease
Gülbay, B. E., Doğan, R., Yıldız, Ö. A., Gürkan, Ö. U., Acıcan, T., Saryal, S., Karabıyıkoğlu, G., & Köse, K. (2006) · Saudi Medical Journal · doi:10.15537/1658-3175.3604 · Cited by 6 · cited 2×
“In Turkey, there are very few studies investigating COPD treatment adherence, and most of those that have been published are single-center studies 8–10 and focus on parameters such as inhaler technique.”
Köktürk, N., Abuharbid, W., Albanna, A. S., Günen, H., Gürgün, A., Khadadah, M. E., Malvolti, E., Soliman, M., van Zyl-Smit, R. N., Zidouni, N., et al. (2019) · International Journal of COPD · doi:10.2147/copd.s215859 · Cited by 5
Baker, C. L., Gupta, S., Goren, A., & Willke, R. J. (2013) · Value in Health · doi:10.1016/j.jval.2013.03.1202 · Cited by 2
Research works printed but not linked: 1
- [26]National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health Reports of the Surgeon General The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General Atlanta, GA Centers for Disease Control and Prevention (US) 2014 24455788
Cited by
Volpato, E., Toniolo, S., Pagnini, F., & Banfi, P. I. (2021) · International Journal of COPD · doi:10.2147/copd.s313841 · Cited by 160
Psychological co-morbidities in COPD: Targeting systemic inflammation, a benefit for both?
Pelgrim, C. E., Peterson, J. D., Gosker, H. R., Schols, A. M. W. J., van Helvoort, A., Garssen, J., Folkerts, G., & Kraneveld, A. D. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.10.001 · Cited by 90
Bhattarai, B., Walpola, R. L., Mey, A., Anoopkumar‐Dukie, S., & Khan, S. A. (2020) · Respiratory Care · doi:10.4187/respcare.07355 · Cited by 96
“Eligible studies included participants of any age or sex with a diagnosis of COPD (regardless of other comorbid conditions) or health care professionals involved in the management of COPD.”
InfluentialXie, H., Jiang, Y., Liu, L., Peng, H., Li, J., & Chen, Z. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111537 · Cited by 46
Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review
Świątoniowska-Lonc, N., Chabowski, M., Polański, J., Mazur, G. J., & Jankowska‐Polańska, B. (2020) · Advances in experimental medicine and biology · doi:10.1007/5584_2019_477 · Cited by 37
Metadata
- Authors
- Kokturk, N., Polatli, M., Oguzulgen, I. K., Saleemi, S., Al Ghobain, M., Khan, J., Doble, A., Tariq, L., Aziz, F., & El Hasnaoui, A.
- Affiliations
- King Faisal Specialist Hospital & Research Centre (SA)
- King Fahd Armed Forces Hospital (SA)
- Venue
- International Journal of Chronic Obstructive Pulmonary Disease
- Publisher
- Informa UK Limited
- Published
- 2018-04
- Volume
- Volume 13
- Pages
- 1377-1388
- ISSN
- 1176-9106 (ISSN-L)
- 1178-2005
- PMC
- PMC5927343
- OpenAlex
- W2802197918
- Semantic Scholar
- 8634df099c8011e09be4c843da62aec03b4e41f4
- Cited by
- 53
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 11 · 2023: 12 · 2022: 3 · 2021: 9 · 2020: 7 · 2019: 4 · 2018: 1
- FWCI
- 5.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of COPD (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Funders
- EuroQol Research Foundation
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Keywords
- chronic obstructive pulmonary disease, medication adherence, predictors of non-adherence, depression, anxiety, quality of life, disease impact, symptom severity, educational attainment, Turkey, Saudi Arabia, Morisky Medication Adherence Scale, COPD Assessment Test, EQ-5D, Hospital Anxiety and Depression Scale, cross-national comparison, patient-reported outcomes
- MeSH terms
- Adult, Age Factors, Cross-Sectional Studies, Depression, Educational Status, Health Status, Humans, Interviews as Topic, Health Knowledge, Attitudes, Practice, Mental Health, Middle Aged, Quality of Life, Surveys and Questionnaires, Risk Factors, Saudi Arabia, Severity of Illness Index, Turkey, Multivariate Analysis, Chi-Square Distribution, Logistic Models, Odds Ratio, Treatment Outcome, Pulmonary Disease, Chronic Obstructive, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.